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ALS CON SNPs 
Discovery                    
Netherlands UMC Utrecht 461 450 317503 311395	   8131	   3440	   4091	   22040	   5891	   0 3 10 3 3 6 450 436 268952	  
Netherlands	   UMC Utrecht 582 629 370404 311395	   8131	   3440	   4091	   22040	   5891	   8 8 2 5 8 17 566 597 268952	  
Netherlands	   UMC Utrecht 0 5974 561466 311395	   8131	   3440	   4091	   22040	   5891	   14 0 7 3 534 20 0 5396 268952	  
Netherlands	   RS-I cohort, The 
Rotterdam Study 




300 328 370404 311395	   8131	   3440	   4091	   22040	   5891	   3 27 11 8 3 2 300 328 268952	  
Sweden Umeå University 
Hospital 
458 455 370404 311395	   8131	   3440	   4091	   22040	   5891	   8 0 23 15 12 22 458 455 268952	  
Ireland Beaumont 
Hospital, Dublin 
220 209 561466 311395	   8131	   3440	   4091	   22040	   5891	   0 0 2 0 0 1 220 209 268952	  
USA NIH 267 267 555351 311395	   8131	   3440	   4091	   22040	   5891	   3 1 6 0 0 3 267 267 268952	  
Total  2261 8328  311395	   8131 3440 4091	   22040	   5891	   37 41 72 66 570 79 2261 8328 268952	  
Replication                    
France Evry 251 724 307790 301686	   7735	   2060	  12579	   9839	   4571	   0 19 6 4 0 6 231 709 266492	  
UK King’s College 
London 
245 221 307790 301686	   7735	   2060	  12579	   9839	   4571	   0 0 4 6 0 5 239 212 266492	  
USA MGH & Atlanta 753 811 307790 301686	   7735	   2060	  12579	   9839	   4571	   0 0 12 11 0 14 736 791 266492	  
Ireland Beaumont 
Hospital, Dublin 
103 127 620901 301686	   7735	   2060	  12579	   9839	   4571	   5 0 0 1 0 0 101 123 266492	  
Total  1352 1883  301686 7735 2060 12579 9839 4571 5 19 22 22 0 25 1307 1835 266492 
QC, quality control; ALS, amyotrophic lateral sclerosis; CON, control; MAF, minor allele frequency; HWE, Hardy-Weinberg Equilibrium. 
	  
